R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 146,806 shares at $19.49 ($2.8M) on 2016-06-24, disclosed to the SEC on 2016-06-28.
Open-market purchase of $2.8M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.35 | 8,909 | $163K | 5.8% |
| 2 | $18.35 | 8,909 | $163K | 5.8% |
| 3 | $19.49 | 42,526 | $829K | 29.3% |
| 4 | $19.49 | 42,526 | $829K | 29.3% |
| 5 | $19.17 | 21,968 | $421K | 14.9% |
| 6 | $19.17 | 21,968 |
| $421K |
| 14.9% |
| Total | $19.26 avg | 146,806 | $2.8M | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |